Michael Borrie Selected Research

Michael Borrie Research Topics

10	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 03/2004
5	Cognitive Dysfunction 01/2021 - 01/2015
4	Dementia (Dementias) 12/2020 - 07/2006
2	Leukoencephalopathies 06/2020 - 10/2019
2	Lacunar Stroke 06/2020 - 10/2019
2	Transient Ischemic Attack 06/2020 - 10/2019
1	Vascular Diseases (Vascular Disease) 11/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021
1	Cerebrovascular Trauma 11/2021
1	Brain Edema (Cerebral Edema) 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2015
1	Disease Progression 02/2009
1	Amyloid Plaque 02/2009
1	Atrophy 02/2009
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 07/2006

3	florbetapirIBA 06/2020 - 01/2018
2	Monoclonal AntibodiesIBA 12/2021 - 01/2013
2	Amyloid beta-PeptidesIBA 12/2021 - 01/2018
2	Apolipoproteins E (ApoE)IBA 01/2021 - 02/2009
2	Nootropic Agents (Nootropics)IBA 01/2015 - 02/2009
1	aducanumabIBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	CholesterolIBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	ApolipoproteinsIBA 01/2021
1	solanezumabIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2015
1	Donepezil (Aricept)FDA LinkGeneric 01/2015
1	Biological ProductsIBA 01/2015
1	ponezumabIBA 01/2013
1	Memantine (Namenda)FDA Link 07/2006
1	Doxycycline (Periostat)FDA LinkGeneric 03/2004
1	Rifampin (Rifampicin)FDA LinkGeneric 03/2004

2	Therapeutics 12/2021 - 07/2006
1	Long-Term Care 12/2020